Clinton Foundation Brokers Deal for Cheaper HIV Generics

Law360, New York (October 24, 2003, 12:00 AM EDT) -- Former U.S. President Bill Clinton's foundation has brokered a deal with four generic-drug companies to cut the cost of AIDS drugs in parts of the developing world, Agence France Press reported.

The agreement with Ranbaxy Laboratories, Cipla and Matrix Laboratories of India and Aspen Pharmacare Holdings of South Africa will cut the price of a commonly used triple-drug regimen by almost a third, to about $0.38 a day per patient. An equivalent dosage of patented drugs currently costs around $1.54.

Clinton said his foundation sent teams...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.